GENTILINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.135
EU - Europa 7.887
AS - Asia 2.760
SA - Sud America 383
OC - Oceania 166
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.061
RU - Federazione Russa 2.897
HK - Hong Kong 1.080
SE - Svezia 1.008
IE - Irlanda 979
SG - Singapore 960
PL - Polonia 804
UA - Ucraina 579
IT - Italia 525
DE - Germania 378
BR - Brasile 353
FI - Finlandia 299
CN - Cina 283
GB - Regno Unito 179
AU - Australia 163
IN - India 153
TR - Turchia 144
FR - Francia 81
CH - Svizzera 71
CI - Costa d'Avorio 62
CA - Canada 50
JO - Giordania 50
NL - Olanda 26
BE - Belgio 25
SC - Seychelles 15
VN - Vietnam 15
MX - Messico 11
ID - Indonesia 9
MA - Marocco 9
BD - Bangladesh 8
UZ - Uzbekistan 8
AR - Argentina 7
IQ - Iraq 7
KR - Corea 7
CO - Colombia 6
EC - Ecuador 6
ES - Italia 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
LV - Lettonia 5
PK - Pakistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
HN - Honduras 4
NZ - Nuova Zelanda 3
ZA - Sudafrica 3
AT - Austria 2
BG - Bulgaria 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
MU - Mauritius 2
OM - Oman 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 26.436
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.781
Fairfield 1.224
Chandler 1.085
Dublin 978
Jacksonville 918
Hong Kong 858
Warsaw 798
Ashburn 596
Woodbridge 594
Cambridge 565
Seattle 547
Singapore 524
Wilmington 453
Houston 440
Princeton 264
Ann Arbor 250
Boardman 200
Boston 194
Buffalo 185
Melbourne 163
Mumbai 128
Medford 124
Lawrence 121
Beijing 118
Altamura 116
Izmir 107
San Diego 72
Bern 70
Norwalk 66
Abidjan 62
Los Angeles 55
Shanghai 54
Dearborn 47
The Dalles 47
Paris 46
Milan 39
Moscow 39
Florence 33
New York 33
Andover 32
Hillsboro 31
Falls Church 30
Kent 29
Auburn Hills 27
Toronto 27
Bremen 25
Brussels 25
Turku 25
Frankfurt Am Main 24
West Jordan 24
Munich 20
Verona 19
São Paulo 18
Washington 17
Salerno 16
Yubileyny 15
Rome 14
London 13
Brooklyn 11
Guangzhou 11
Dong Ket 10
Belo Horizonte 9
Laurel 9
Chicago 8
Rio de Janeiro 8
Tashkent 8
Frankfurt am Main 7
Helsinki 7
Jakarta 7
Ottawa 7
Phoenix 7
Saint Petersburg 7
Nanjing 6
Philadelphia 6
Pune 6
Redmond 6
Atlanta 5
Bagno a Ripoli 5
Bishkek 5
Curitiba 5
Kunming 5
Maceió 5
Newark 5
Porto Alegre 5
Riga 5
Sorocaba 5
Stockholm 5
Tappahannock 5
Amman 4
Baku 4
Brasília 4
Brno 4
Cairo 4
Catania 4
Changsha 4
Dallas 4
Dhaka 4
Fortaleza 4
Las Vegas 4
Ribeirão Preto 4
Totale 16.673
Salva come PNG Salva come JPEG
Nome #
Serum hepatitis delta virus RNA in patients with delta hepatitis and in liver graft recipients 1.137
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 282
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 273
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 261
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 260
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 243
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 229
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 174
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 166
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 163
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 161
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles 158
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 154
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 151
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 151
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 149
Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning 148
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 145
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 144
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 142
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 142
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 142
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 139
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 138
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 137
Analysis of HCV persistence in patients with sustained virological response 136
Ascites and hepatorenal syndrome 135
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 135
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 135
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 135
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 134
Infection of peripheral mononuclear blood cells by hepatitis C virus 132
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 131
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 131
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 131
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 130
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients 126
Torasemide in the treatment of patients with cirrhosis and ascites. 126
Loop diuretic therapy in liver cirrhosis with ascites 126
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 126
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 126
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 126
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 126
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 126
T(14;18) translocation in chronic hepatitis C virus infection 125
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 124
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 124
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 124
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 124
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 123
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 123
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 122
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 122
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 122
Expression of platelet-derived growth factor in a model of acute liver injury. 121
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 120
The cellular and molecular basis of liver fibrogenesis. 119
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 119
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 119
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 118
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 118
Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation 117
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 117
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 117
Respiratory mechanics in patients with tense cirrhotic ascites. 117
Pathogenesis and treatment of ascites in hepatic cirrhosis. 115
Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. 115
Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. 115
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis 114
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 114
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 114
Defective signal transduction in platelets from cirrhotic patients is associated with increased cyclic AMP and cyclic GMP content. 113
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 111
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 111
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 111
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 111
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 111
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 111
Hepatitis C virus lymphotropism and possible pathogenetic implications 110
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 110
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 110
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 110
Crioglobulinemia e linfoma in corso di infezione da HCV 109
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 109
CXCR3-binding chemokines as survival factors in human hepatic stellate cells. 109
Transforming growth factor beta1 regulates platelet derived growth factor receptor beta subunit in human liver fat storing cells 106
Uveitis in autoimmune hepatitis: a case report. 106
Lipid perodixation increases procollagen alpha 1 (I) gene expression and synthesis in human liver fat storing cells. 106
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 105
Drugs and the Liver. Pharmacokinetc factors and drug-induced liver disease 105
IGF-I IS A SURVIVAL FACTOR FOR HUMAN HEPATIC STELLATE CELLS (HSC): INVOLVEMENT OF PI 3-K AND C-AKT 105
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 104
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis 104
Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. 104
Pathogenesis and treatment of ascites in hepatic cirrhosis. 104
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 104
Renal functional impairment and sodium retention in liver cirrhosis. 103
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 103
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. 103
Endothelin-1 is overexpressed in cirrhotic liver and exerts multiple effects on activated human hepatic stellate cells. 102
Totale 14.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202046 0 0 0 0 0 0 0 0 0 0 0 46
2020/20212.068 202 88 213 194 57 336 37 197 151 279 134 180
2021/20221.574 25 192 46 72 42 51 49 80 66 42 380 529
2022/20234.195 429 428 201 320 435 841 572 250 469 28 120 102
2023/20241.257 65 180 278 79 77 147 35 263 23 31 41 38
2024/202510.354 307 1.102 734 1.580 3.550 1.086 94 621 544 212 318 206
Totale 26.480